Biotech Metropolitan Women

Celebrating women leading the business of life science innovation in metro New York and beyond

Veta Obazenu

Veta is a Medical Affairs professional at big pharma and previously worked in clinical trials at a CRO. She attended New Jersey Institute of Technology for her undergraduate degree in Computer Science and attended Johns Hopkins University for graduate studies in Biotechnology with concentration in Enterprise. Veta champions for women innovators and enjoys staying current with trends in the biotech sector. She is also a contributing author at Hopkins Biotech Network magazine, The Transcript.

Veta Obazenu

In silico: How Envisagenics is using AI to Discover Biomarkers and New Therapies for Lung Cancer and Genetic Disease

Lung cancer leads in mortality ahead of all other cancer deaths in both developed and undeveloped countries and is the second most commonly diagnosed cancer after breast cancer. While the disease is showing nominal decline due to successful public health measures (like cessation programs) and people abstaining from smoke and tobacco products, lung and bronchial cancer …

In silico: How Envisagenics is using AI to Discover Biomarkers and New Therapies for Lung Cancer and Genetic Disease Read More »

BIO’s New CEO Michelle McMurry-Heath- Exemplifying the Diverse Biotech Ecosystem

At a time when most companies are challenged with planning their initial diversity and inclusion dialogues, The Biotechnology Innovation Organization (BIO) had already introduced their first black, woman CEO.  She is the third chief executive of the organization that made their announcement on May 14, 2020 and Dr. Michelle McMurry-Heath assumed this role as President …

BIO’s New CEO Michelle McMurry-Heath- Exemplifying the Diverse Biotech Ecosystem Read More »

The Coincidence of Science and Art: Expressions from New York Pathologist and Artist Zahra Jlayer

Scientists and artists uniquely strive to conceptualize the impalpable world both around and within us. To understand the interplay of data and emotions that compose our entire existence, one would have to respect, equally, the natural and social sciences. Nurtured by the complexities of nature, is a delicate arrangement of mind, body and soul and …

The Coincidence of Science and Art: Expressions from New York Pathologist and Artist Zahra Jlayer Read More »

Where The Women Are Networking At JP Morgan Healthcare Conference

At the start of the new year, industry professionals travel far and wide to make their appearance at the JP Morgan Healthcare Conference in San Fransisco. The week isn’t worthwhile if attendees haven’t planned to have their agenda full with seats at first hand industry announcements, informative symposiums and networking receptions. The days begin early …

Where The Women Are Networking At JP Morgan Healthcare Conference Read More »

Trending at the 38th Annual JP Morgan Healthcare Conference| Medtech, M&A, Biosimilars, China

This year marks a new decade and the 38th annual JP Morgan Healthcare conference at the Westin St. Francis. The San Francisco based investment firm, Hambrecht & Quist began hosting the conference in 1983 to 20 companies and roughly 200 attendees. Chase acquired the firm in 2000, and now, in 2020, has been hosting this …

Trending at the 38th Annual JP Morgan Healthcare Conference| Medtech, M&A, Biosimilars, China Read More »

Concarlo Holdings Combats Resistant Metastatic Breast Cancer with Dual Receptor Therapeutic

Breast cancer is the most common cancer diagnosed among women. Over a lifetime, approximately 1 in 8 women develop breast cancer. When treated early, survival rates at five years are 100%. However, for more advanced states, survival rates decline significantly. Over 3 million women live with a current or previous diagnosis of breast cancer. Any …

Concarlo Holdings Combats Resistant Metastatic Breast Cancer with Dual Receptor Therapeutic Read More »

How Do You Define Power? Crain’s 2019 Most Powerful Women in New York Luncheon

Crain’s New York Business published their 2019 list of Most Powerful Women in New York this past June. The list recognizes 50 prominent business and civic leaders that have made a positive impact on the city’s culture and economic growth to date. In celebration of that list, Crain’s hosted a luncheon on Tuesday complete with …

How Do You Define Power? Crain’s 2019 Most Powerful Women in New York Luncheon Read More »

ESG, SRI and Impact Investing: Women as Benefactors and Beneficiaries in RI

Responsible Investing (RI) has increasingly become a rule for today’s socially conscience capitalists that want to implement their value set into portfolio construction. Women, who now account for 51% of investable wealth, and millennials, are proving to traditional investment houses that their money has power. These investors deem it necessary to consider the ethical impact …

ESG, SRI and Impact Investing: Women as Benefactors and Beneficiaries in RI Read More »

Vertex in Q2: Announces Female CEO & favorable earnings amidst Cystic Fibrosis drug reimbursement woes

Vertex Pharmaceuticals will be appointing their first ever female CEO to head their billion dollar company.  Dr. Reshma Kewalramani, will be replacing Dr. Jeffrey Leiden on April 1, 2020, who will continue on as Executive Chairman. This shift in leadership is announced in the midst of scrutiny the pharmaceutical company is still facing surrounding the …

Vertex in Q2: Announces Female CEO & favorable earnings amidst Cystic Fibrosis drug reimbursement woes Read More »

New York Metro and Its Innovative Women Scientists and Entrepreneurs.

We are in the course of Metropolitan New York executing its plan to become a major hub for biotechnology. We certainly have the appropriate lattice of talent- major medical research institutions in the hotbed of Pharm Country with direct subway lines to venture capital. The city is excited about the magnitude of unleashed potential finally …

New York Metro and Its Innovative Women Scientists and Entrepreneurs. Read More »